Cardio-oncology & other

Prevalence of Sleep Apnea and Echocardiographic Correlates in a Community-Based Cohort of Cardio-Oncology Patients

JACC AdvPublished Cross-sectional study

Authors' conclusion

These observations suggest OSA be considered in risk algorithms for CTRCD.

Study context

Population
Community-based cardio-oncology patients
Participants
218 patients
Exposure
Obstructive sleep apnea (OSA) status
Outcome
Prevalence of OSA and association with pretreatment LVEF and GLS
Methodological detailscommunity-based cohort
  • Community-based cohort

Main finding

As reported in the abstract

OSA prevalence

Prevalence of OSA (84/218)

38.5%

Observational data: associations, not effects.

Further findings

OutcomeOR (95% CI)
Abnormal GLS (multivariable) · pretreatmentUntreated OSAvs Low OSA riskStrongest associationvs other CV risk factorsMultivariable adjusted4.13 (1.32–12.93)

Baseline abnormal global longitudinal strain (GLS) and left ventricular ejection fraction (LVEF) by OSA subgroup · pretreatment

Abnormal GLS, not abnormal LVEF, significantly different between the four subgroups

Original publication

Prevalence of Sleep Apnea and Echocardiographic Correlates in a Community-Based Cohort of Cardio-Oncology Patients. JACC Adv. Published 28 October 2025. doi:10.1016/j.jacadv.2025.102256

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.